Staphylococcus aureus with decreased susceptibility to glycopeptides in cystic fibrosis patients

被引：9

作者：

Filleron, Anne ^{[2
]}

Chiron, Raphael ^{[3
]}

Reverdy, Marie-Elisabeth ^{[4
]}

Jean-Pierre, Helene ^{[1
,5
]}

Dumitrescu, Oana ^{[4
]}

Aleyrangues, Linda ^{[5
]}

Counil, Francois ^{[3
]}

Jumas-Bilak, Estelle ^{[1
]}

Marchandin, Helene ^{[1
,5
]}

机构：

[1] Univ Montpellier 1, Equipe Pathogenes & Environm, UMR 5119, UFR Pharm,CNRS,IRD,IFREMER,UM1,UM2, F-34093 Montpellier 5, France

[2] Hop Arnaud de Villeneuve, Ctr Hosp Reg Univ Montpellier, Serv Pediat Gen, Immunol Clin, F-34295 Montpellier 5, France

[3] Hop Arnaud de Villeneuve, Ctr Hosp Reg Univ Montpellier, Ctr Ressources & Competences Mucoviscidose, Serv Pediat & Malad Resp 1, F-34295 Montpellier 5, France

[4] Fac Med Laennec, INSERM, E0230, Ctr Natl Reference Staphylocoques, F-69008 Lyon, France

[5] Hop Arnaud de Villeneuve, Ctr Hosp Reg Univ Montpellier, Bacteriol Lab, F-34295 Montpellier 5, France

来源：

JOURNAL OF CYSTIC FIBROSIS | 2011年 / 10卷 / 05期

关键词：

Glycopeptides; Resistance; Staphylococcus aureus; GISA; Cystic fibrosis; METHICILLIN-RESISTANT; CLINICAL-SIGNIFICANCE; VANCOMYCIN SUSCEPTIBILITY; REDUCED SUSCEPTIBILITY; PULMONARY INFECTION; EPIDEMIOLOGY; EMERGENCE; STRAINS;

D O I：

10.1016/j.jcf.2011.05.001

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

We report the isolation of Staphylococcus aureus with decreased susceptibility to glycopeptides in five CF patients and review the clinical and microbiological features of these cases. Three patients presented with pulmonary exacerbation that may be attributed to these strains and two of them were successfully treated using linezolid therapy. Glycopeptide-intermediate S. aureus (GISA) strains isolated in two patients were susceptible to methicillin, while the three other patients harbored rnethicillin-resistant GISA. Rarely reported in CF, GISA may remain underestimated due to the difficulty of detection, and both clinicians and microbiologists should be aware of the GISA emergence in CF patients' population. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

引用

页码：377 / 382

页数：6

共 50 条

[1] Utility of the Etest GRD for detecting Staphylococcus aureus with reduced susceptibility to glycopeptides in cystic fibrosis patients
Filleron, A.
Chiron, R.
Reverdy, M. -E.
Jean-Pierre, H.
Dumitrescu, O.
Aleyrangues, L.
Counil, F.
Jumas-Bilak, E.
Marchandin, H.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (04) : 599 - 604
[2] Utility of the Etest GRD for detecting Staphylococcus aureus with reduced susceptibility to glycopeptides in cystic fibrosis patients
A. Filleron
R. Chiron
M.-E. Reverdy
H. Jean-Pierre
O. Dumitrescu
L. Aleyrangues
F. Counil
E. Jumas-Bilak
H. Marchandin
European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 599 - 604
[3] LONGITUDINAL SURVEY OF DECREASED SUSCEPTIBILITY TO GLYCOPEPTIDES IN STAPHYLOCOCCUS AUREUS CHRONICALLY COLONIZED CF PATIENTS
Rubira, L.
Farel, M.
Nassibou, S.
Cathala, L.
Dupont, C.
Jumas-Bilak, E.
Laurent, F.
Chiron, R.
Marchandin, H.
PEDIATRIC PULMONOLOGY, 2015, 50 : 315 - 315
[4] Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients
Roch, Melanie
Varela, Maria Celeste
Taglialegna, Agustina
Rose, Warren E.
Rosato, Adriana E.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
[5] Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus
Nannini, Esteban
Murray, Barbara E.
Arias, Cesar A.
CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (05) : 516 - 521
[6] Staphylococcus aureus and cystic fibrosis
Mimica, Marcelo J.
JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (01) : 71 - 71
[7] STAPHYLOCOCCUS AUREUS IN CYSTIC FIBROSIS
Moonnumakal, S. P.
Hulten, K. G.
Mason, E. O.
Kaplan, S. L.
Hiatt, P. W.
PEDIATRIC PULMONOLOGY, 2010, : 336 - 336
[8] Linezolid Resistant Staphylococcus Aureus in Patients With Cystic Fibrosis
Fischer, A. J.
Pitcher, N.
Feder, A.
Bolden, N.
Zirbes, C.
Thurman, A.
Reeb, V.
Moustafa, A.
Porterfield, H.
Planet, P. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[9] Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
Esposito, Susanna
Pennoni, Guido
Mencarini, Valeria
Palladino, Nicola
Peccini, Laura
Principi, Nicola
FRONTIERS IN PHARMACOLOGY, 2019, 10
[10] Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides
El Solh, N
Davi, M
Morvan, A
Damon, HA
Marty, N
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) : 691 - 694

← 1 2 3 4 5 →